Wegovy - A higher-dose injection approved for weight loss
Only a handful of other compounds show similar potential, including resveratrol, which activates sirtuins linked to telomere preservation
They are evidence-based supplements with human clinical trials showing meaningful results
A significant portion are people who play tennis or golf recreationally and have been dealing with tendon tears or chronic overuse injuries for months
Based on the current stage of clinical development and estimated trial completion dates registered on ClinicalTrials.gov, a realistic earliest possible timeline might be considered as follows: 20252026: Completion of key phase 3 TRIUMPH trial data 20262027: Potential regulatory submission to the MHRA (and FDA/EMA in parallel) 20272028: Possible MHRA marketing authorisation, subject to satisfactory review 2028 onwards: NICE technology appraisal and potential NHS commissioning decision These timelines are speculative and depend on multiple variables, including trial outcomes, the completeness of the regulatory submission, MHRA review timelines, and NICE deliberations
10.3389/fphar.2024.1438926 Front
